Moderna (bStocks Tokenized Stock) vs NVIDIA (bStocks Tokenized Stock)

NVIDIA (bStocks Tokenized Stock) (NVDAB) is 84.5× the size of Moderna (bStocks Tokenized Stock) (MRNAB) by market capitalisation. Over the past 90 days, MRNAB is ahead by 72.4 percentage points (MRNAB +32.4% against NVDAB -40.0%). Their daily returns move barely together (correlation 0.31 across 80 shared trading days). MRNAB has been the more volatile of the two, at 98% annualised against NVDAB's 46%.

Correlation
0.31
Size ratio
1 : 84.5
Ahead over 90 days
MRNAB
Moderna (bStocks Tokenized Stock)MRNAB

$199.6100

24h
-0.30%
Market cap
$2.22M
Volume 24h
$25.59M
Volatility (ann.)
98%
NVIDIA (bStocks Tokenized Stock)NVDAB

$129.8600

24h
-9.84%
Market cap
$187.80M
Volume 24h
$135.19M
Volatility (ann.)
46%
MRNAB 1.2%Share of the two combined market caps98.8% NVDAB

Performance

MRNABNVDAB

  1. 7 days-8.42%-19.46%MRNAB
  2. 30 days-18.71%-40.93%MRNAB
  3. 90 days+32.40%-40.04%MRNAB

Correlation

0.31over 80 shared trading days

−1 opposite0 unrelated+1 in step
7d: insufficient data30d: 0.3390d: 0.311y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

MetricMRNABNVDAB
Max drawdown (400d)-27.9%-46.0%
Risk-adjusted return (90d)0.33-0.77

Relative strength over 90 days: MRNAB outperformed NVDAB by 130.3% — measured on the MRNAB/NVDAB ratio, so it holds regardless of market direction.